Victory Capital Management’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-71,020
| Closed | -$433K | – | 2714 |
|
|
2022
Q4 | $433K | Sell |
71,020
-44,530
| -39% | -$272K | ﹤0.01% | 2055 |
|
|
2022
Q3 | $1.38M | Sell |
115,550
-2,980
| -3% | -$35.6K | ﹤0.01% | 1591 |
|
|
2022
Q2 | $1.5M | Buy |
118,530
+32,490
| +38% | +$410K | ﹤0.01% | 1568 |
|
|
2022
Q1 | $969K | Sell |
86,040
-30,100
| -26% | -$339K | ﹤0.01% | 1832 |
|
|
2021
Q4 | $2.06M | Buy |
116,140
+20,870
| +22% | +$370K | ﹤0.01% | 1546 |
|
|
2021
Q3 | $2.19M | Sell |
95,270
-770
| -0.8% | -$17.7K | ﹤0.01% | 1572 |
|
|
2021
Q2 | $2.24M | Sell |
96,040
-6,370
| -6% | -$148K | ﹤0.01% | 1600 |
|
|
2021
Q1 | $3.19M | Sell |
102,410
-4,340
| -4% | -$135K | ﹤0.01% | 1499 |
|
|
2020
Q4 | $4.25M | Buy |
+106,750
| New | +$4.25M | ﹤0.01% | 1282 |
|